10.01.2022 MRT bei ungeborenen Kindern ermöglicht eine frühzeitige Erkennung von Fehlbildungen der Organemore
10.01.2022 Valneva Confirms Clinical Trial and Regulatory Submission Timelines for its Inactivated COVID-19 Vaccine Candidate VLA2001more
10.01.2022 Novid20: Viennese health-tech startup adopts Covid tests in all elementary schools in Bavariamore
10.01.2022 Technopole 2021: NÖ Forschungs- und Innovationshotspots gewinnen weiter an Attraktivitätmore
23.12.2021 Valneva and Scottish Enterprise in Advanced Discussions for Major Grant to Complete Livingston Sitemore
22.12.2021 Austrian researchers release the "sugar brake" and develop highly effective SARS-CoV-2 receptor mock-upmore
22.12.2021 Valneva Announces Positive Lot-to-Lot Consistency Trial Results for its Single-Shot Chikungunya Vaccine Candidatemore
16.12.2021 Valneva Announces Positive Homologous Booster Data for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001more
16.12.2021 Evercyte joins EU LIFESAVER project to study ‘hidden’ maternal and fetal health influencesmore
16.12.2021 invIOs goes live with unique cell therapy platform and clinical-stage immuno-oncology pipelinemore
15.12.2021 COVID-19-Schutzimpfung bei Immungeschwächten: Forscher*innen finden wichtigen Zelltyp zur Vorhersage der Immunantwortmore